GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » Debt-to-Revenue

Oventus Medical (ASX:OVN) Debt-to-Revenue : 0.40 (As of Dec. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Oventus Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was A$0.20 Mil. Oventus Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was A$0.24 Mil. Oventus Medical's annualized Revenue for the quarter that ended in Dec. 2021 was A$1.11 Mil. Oventus Medical's annualized Debt-to-Revenue for the quarter that ended in Dec. 2021 was 0.40.


Oventus Medical Debt-to-Revenue Historical Data

The historical data trend for Oventus Medical's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical Debt-to-Revenue Chart

Oventus Medical Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21
Debt-to-Revenue
- - - 0.11 0.49

Oventus Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.30 0.10 0.58 0.50 0.40

Competitive Comparison of Oventus Medical's Debt-to-Revenue

For the Medical Devices subindustry, Oventus Medical's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oventus Medical's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oventus Medical's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Oventus Medical's Debt-to-Revenue falls into.



Oventus Medical Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Oventus Medical's Debt-to-Revenue for the fiscal year that ended in Jun. 2021 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.219 + 0.32) / 1.09
=0.49

Oventus Medical's annualized Debt-to-Revenue for the quarter that ended in Dec. 2021 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.203 + 0.24) / 1.108
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2021) Revenue data.


Oventus Medical Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Oventus Medical's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Oventus Medical (ASX:OVN) Business Description

Traded in Other Exchanges
N/A
Address
1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines